Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
MNDY - Monday.Com Ltd - Stock Price Chart
TickerMNDY [NASD]
CompanyMonday.Com Ltd
CountryIsrael
IndustrySoftware - Application
Market Cap10.60BEPS (ttm)-0.07
P/E-EPS this Y7.65%
Forward P/E82.81EPS next Y31.41%
PEG-EPS past 5Y64.20%
P/S14.53EPS next 5Y-
P/B13.03EPS Q/Q866.03%
Dividend-Sales Q/Q35.12%
Insider Own32.20%Inst Own74.95%
Insider Trans0.00%Inst Trans-1.85%
Short Float6.70%EarningsMay 15/b
Analyst Recom1.53Target Price245.51
Avg Volume777.37K52W Range122.13 - 239.22
monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.
TMCI - Treace Medical Concepts Inc - Stock Price Chart
TickerTMCI [NASD, RUT]
CompanyTreace Medical Concepts Inc
CountryUSA
IndustryMedical Devices
Market Cap367.72MEPS (ttm)-0.89
P/E-EPS this Y-11.61%
Forward P/E-EPS next Y6.94%
PEG-EPS past 5Y-70.68%
P/S1.88EPS next 5Y-
P/B2.91EPS Q/Q-31.91%
Dividend-Sales Q/Q21.12%
Insider Own26.90%Inst Own65.67%
Insider Trans5.85%Inst Trans10.85%
Short Float6.71%EarningsMay 07/a
Analyst Recom2.71Target Price8.42
Avg Volume871.41K52W Range3.92 - 27.70
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Treace John T.Chief Executive OfficerMay 14 '24Buy5.12150,000767,8056,243,095May 14 06:19 PM
Kiernan Jane EDirectorMay 14 '24Buy5.1719,356100,00124,941May 14 06:20 PM
Treace John T.Chief Executive OfficerMay 13 '24Buy4.56150,000683,4906,093,095May 13 06:07 PM
TREACE JAMES TDirectorMay 13 '24Buy4.54145,000657,9811,039,441May 13 07:47 PM
MOTT RICHARD WDirectorMay 13 '24Buy4.3836,802161,0901,027,753May 13 07:48 PM
KPLT - Katapult Holdings Inc - Stock Price Chart
TickerKPLT [NASD]
CompanyKatapult Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap84.25MEPS (ttm)-9.03
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-39.02%
P/S0.38EPS next 5Y-
P/B-EPS Q/Q-21.66%
Dividend-Sales Q/Q16.10%
Insider Own46.11%Inst Own18.74%
Insider Trans-0.00%Inst Trans-45.80%
Short Float3.49%EarningsMay 15/b
Analyst Recom3.00Target Price16.00
Avg Volume12.76K52W Range8.26 - 24.76
Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zayas OrlandoChief Executive OfficerFeb 15 '24Option Exercise0.009190129,832Feb 21 05:20 PM
TOWERS CHRISTOPHERChief Accounting OfficerFeb 15 '24Option Exercise0.00197011,334Feb 21 05:17 PM
Medlin DerekChief Operating OfficerFeb 15 '24Option Exercise0.00276049,709Feb 21 05:14 PM
Chopra ChandanChief Technology OfficerFeb 15 '24Option Exercise0.00786022,473Feb 21 05:11 PM
Zayas OrlandoChief Executive OfficerNov 29 '23Sale12.58563128,913Dec 01 04:34 PM
TLPH - Talphera Inc. - Stock Price Chart
TickerTLPH [NASD]
CompanyTalphera Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap20.39MEPS (ttm)-0.89
P/E-EPS this Y35.14%
Forward P/E-EPS next Y1.59%
PEG-EPS past 5Y39.67%
P/S31.37EPS next 5Y-
P/B1.25EPS Q/Q78.63%
Dividend-Sales Q/Q-
Insider Own3.83%Inst Own39.36%
Insider Trans1.56%Inst Trans2.77%
Short Float0.90%EarningsMay 14/a
Analyst Recom1.00Target Price4.42
Avg Volume87.91K52W Range0.43 - 1.61
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Angotti Vincent J.Chief Executive OfficerDec 13 '23Buy0.7310,0007,268101,805Dec 14 08:11 AM
Angotti Vincent J.Chief Executive OfficerSep 11 '23Buy0.8010,0007,95091,805Sep 11 07:13 PM
Palmer Pamela PChief Medical OfficerAug 25 '23Sale1.097,4428,10430,753Aug 25 04:45 PM
Palmer Pamela PChief Medical OfficerAug 24 '23Sale1.179,51411,13138,195Aug 25 04:45 PM
PSTX - Poseida Therapeutics Inc - Stock Price Chart
TickerPSTX [NASD, RUT]
CompanyPoseida Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap332.95MEPS (ttm)-1.18
P/E-EPS this Y-8.94%
Forward P/E-EPS next Y-20.44%
PEG-EPS past 5Y-12.83%
P/S4.04EPS next 5Y2.70%
P/B3.93EPS Q/Q43.86%
Dividend-Sales Q/Q172.09%
Insider Own29.83%Inst Own47.87%
Insider Trans0.00%Inst Trans56.79%
Short Float8.89%EarningsMay 14/a
Analyst Recom1.00Target Price14.00
Avg Volume695.56K52W Range1.54 - 4.27
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
WOOF - Petco Health and Wellness Co Inc - Stock Price Chart
TickerWOOF [NASD]
CompanyPetco Health and Wellness Co Inc
CountryUSA
IndustrySpecialty Retail
Market Cap642.95MEPS (ttm)-4.78
P/E-EPS this Y-169.36%
Forward P/E36.38EPS next Y205.04%
PEG-EPS past 5Y-25.03%
P/S0.10EPS next 5Y48.80%
P/B0.54EPS Q/Q-168.35%
Dividend-Sales Q/Q6.12%
Insider Own49.56%Inst Own55.75%
Insider Trans0.02%Inst Trans-6.99%
Short Float20.75%EarningsMay 22/b
Analyst Recom2.67Target Price2.68
Avg Volume3.71M52W Range1.41 - 10.73
Petco Health & Wellness Company, Inc. engages in the provision of pet health and wellness services. It operates across the U.S., Mexico and Puerto Rico, including a growing network, store veterinary hospitals, and offer a complete online resource for pet health and wellness. The firm offers grooming, as well as in-store and online training. The company was founded in 1965 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRIGGS GARY SDirectorDec 01 '23Buy3.3330,00099,92470,085Dec 04 07:29 PM
IKT - Inhibikase Therapeutics Inc - Stock Price Chart
TickerIKT [NASD]
CompanyInhibikase Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap11.66MEPS (ttm)-3.62
P/E-EPS this Y51.12%
Forward P/E-EPS next Y32.95%
PEG-EPS past 5Y-23.31%
P/S44.86EPS next 5Y-
P/B1.01EPS Q/Q33.63%
Dividend-Sales Q/Q-100.00%
Insider Own14.50%Inst Own6.79%
Insider Trans0.00%Inst Trans-20.59%
Short Float2.44%EarningsMar 27/a
Analyst Recom1.00Target Price17.50
Avg Volume58.95K52W Range0.79 - 4.35
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in developing protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
SNTG - Sentage Holdings Inc - Stock Price Chart
TickerSNTG [NASD]
CompanySentage Holdings Inc
CountryChina
IndustryCredit Services
Market Cap6.10MEPS (ttm)-0.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S40.66EPS next 5Y-
P/B0.50EPS Q/Q48.63%
Dividend-Sales Q/Q1008.80%
Insider Own62.24%Inst Own0.00%
Insider Trans0.00%Inst Trans30.16%
Short Float1.04%Earnings-
Analyst Recom-Target Price-
Avg Volume36.89K52W Range1.47 - 8.45
Sentage Holdings, Inc. provides financial services, which offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China. The company was founded on September 16, 2019 and is headquartered in Shanghai, China.
GBIO - Generation Bio Co - Stock Price Chart
TickerGBIO [NASD, RUT]
CompanyGeneration Bio Co
CountryUSA
IndustryBiotechnology
Market Cap271.94MEPS (ttm)-2.56
P/E-EPS this Y15.23%
Forward P/E-EPS next Y37.32%
PEG-EPS past 5Y-20.44%
P/S27.30EPS next 5Y-
P/B2.06EPS Q/Q-110.55%
Dividend-Sales Q/Q-
Insider Own27.00%Inst Own66.80%
Insider Trans3.14%Inst Trans0.85%
Short Float3.61%EarningsMay 13/a
Analyst Recom1.86Target Price7.50
Avg Volume244.79K52W Range0.86 - 6.98
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Samayoa PhillipCHIEF STRATEGY OFFICERJan 02 '24Sale1.622,4453,961107,256Jan 03 04:35 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 02 '24Sale1.622,4453,9615,828Jan 03 04:35 PM
Appelhans DannielleDirectorDec 08 '23Buy1.797,36313,1807,363Dec 11 04:30 PM
Appelhans DannielleDirectorDec 08 '23Buy1.826371,15912,637Dec 11 04:30 PM
Rowland Charles A JrDirectorDec 04 '23Buy1.50150,000225,000534,757Dec 05 04:30 PM
ARQT - Arcutis Biotherapeutics Inc - Stock Price Chart
TickerARQT [NASD, RUT]
CompanyArcutis Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.08BEPS (ttm)-2.92
P/E-EPS this Y48.37%
Forward P/E-EPS next Y32.37%
PEG-EPS past 5Y-48.07%
P/S10.20EPS next 5Y9.80%
P/B4.82EPS Q/Q73.03%
Dividend-Sales Q/Q1574.06%
Insider Own15.37%Inst Own88.08%
Insider Trans-0.24%Inst Trans9.77%
Short Float22.19%EarningsMay 14/a
Analyst Recom1.33Target Price18.67
Avg Volume3.77M52W Range1.76 - 13.17
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watanabe Todd FranklinSee RemarksMay 02 '24Sale8.7413,783120,433860,750May 03 04:22 PM
Burnett PatrickSee RemarksMay 02 '24Sale8.749,55583,490259,745May 03 04:22 PM
Matsuda MasaruSee RemarkMay 02 '24Sale8.745,01643,829185,408May 03 04:22 PM
Moore Matthew RichardSVP and Chief Business OfficerMay 02 '24Sale8.744,68140,902145,505May 03 04:29 PM
Heron Patrick JDirectorMar 04 '24Buy9.5021,052199,9948,785,284Mar 06 04:28 PM
123456781020